Pulse oximetry sensors

Nellcor™ OxySoft™ SpO₂ sensor

Pulse oximetry sensors

Nellcor™ OxySoft™ SpO₂ sensor

The Nellcor™ OxySoft™ SpO₂ sensor is the first pulse oximetry sensor to use a silicone adhesive to protect fragile skin and improve repositionability.

Description

Connect with every touch.

For your most critical neonatal and adult patients, every touch has an impact on their well-being. Continuous monitoring devices should minimize impact and maximize performance. So, we designed our enhanced Nellcor™ OxySoft™ SpO2 sensor to perform better in low perfusion and thick tissue,1 stay on longer, and be repositioned without pulling on or damaging fragile skin.2

With brighter LEDs, a new silicone adhesive, and a lower profile, compared to MaxN sensors.3

Once you touch it, you’ll know.

Request a complimentary Nellcor™ OxySoft™ sensor sample kit by filling out the form.
 

View a sample kit of the Nellcor™ OxySoft™ SpO₂ sensor.

For your most critical patients

Introducing the Nellcor™ OxySoft™ SpO2 sensor — designed with your most critical patients in mind.

See the OxySoft™ patient sensor attached to a finger, providing pulse oximetry readings.

Critical decisions need reliable readings.

  • LEDs shine seven times brighter, but not hotter
  • 50% better signal acquisition and 50% reduction in time to post in simulated low perfusion and thicker tissue
The Nellcor™ OxySoft™ SpO₂ sensor uses a silicone adhesive to protect fragile skin and improve repositionability.

Fragile skin deserves protection.

  • Removes 87% less skin cells from fragile skin 
  • Stays in place longer, even through motion§
See a closeup of the Nellcor™ portable SpO₂ patient monitoring system from Medtronic.

Busy days demand efficiency.

  • Is easy to peel apart and reposition§
  • Withstands up to 18 repositions
  • Helps you use less and get more time back in your day

Ordering information

Item number Description Units per box
OXYSOFTN Neonates — adults more than 40 kg  24

 

The Nellcor™ pulse oximetry monitoring system should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment.

Based on validation data in head-to-head clinical testing compared to MaxN CSR 2021 0312v1 S20-12.

During internal head-to-head bench test compared to MaxN with validated test equipment.

§ Based on a hands-on evaluation with clinicians.


  1. Based on internal test report RE00368468, expanded claims bench test. 2021.
  2. Based on CSR 2021 03 12 v1.0 - CyberDERM S20- 14 multiple reposition peel adhesion on human skin validation, OxySoft™N. 2021.
  3. Based on internal test report RE00357465, marketing validation. 2020.